This site is intended for Healthcare Professionals only

Class 4 Drug Alert: Pregabalin 75mg capsules

Latest

Class 4 Drug Alert: Pregabalin 75mg capsules

Product details: Teva UK Limited, Pregabalin 75mg Capsules, PL 00289/1947.

Batch number: 018111
Expiry date: Dec 2017
Pack size: 1 x 56
First distributed: 15 Jul 2015

Alert details

Teva UK Limited has notified MHRA of a printing error on some blisters of Pregabalin 75mg capsules from the above batch.

The strength is printed in several positions on the foil lid of the blisters. For affected units, the strength is printed incorrectly, as 25mg instead of 75mg, in one position on the foil. The strength is printed correctly in the remaining positions on the foil. The strength is stated correctly on carton labels and in the patient information leaflet. Approximately 1 in 3 blisters are affected by this issue, hence the majority of cartons from this batch are likely to contain 1 or 2 affected blisters.

To ensure continuity of supply, affected stock will not be recalled. No further stock with this error will be released to the market, however.

For general enquiries please contact Teva UK Customer Service Team on 0800 590502.

For medical information enquiries contact Teva UK limited by telephone on 0207 5407117 or by email to medinfo@tevauk.com.

Recipients of this drug alert should bring it to the attention of relevant contacts by copy of this letter. Local area teams are asked to forward this to relevant clinics, general practitioners and community pharmacists.

Copy Link copy link button

Latest

Discover the latest pharmacy news with daily updates and information to keep you in the know.

Share: